• 한국식품과학회지
• /
• 제23권5호
• /
• pp.627-632
• /
• 1991

본 실험에서는 국산 유아용 조제분유의 열처리 정도를 파악하기 위하여 HMF 함량, lactulose 함량, 유청단백질 변성율 등을 측정하였다. 조제분유의 HMF 함량은 $21.0{\sim}43.9{\mu}mol/l$로 분말상의 경우 각종 영양성분의 함량이 더 강화된 (ii)단계 제품에서 많은 HMF 함량을 보였으나, 액상의 경우 can 포장용 제품에서 더 많았다. 조제분유의 lactulose 함량은 분말상에서 $2.5{\sim}11.4mg/100ml$였고 액상에서 $27.0{\sim}164.8mg/100ml$으로 제품의 형태에 따라 많은 차이가 있었다. ADPI에서 제시한 열처리 등급을 기준으로 분류했을 때 대부분의 조제분유 제품이 medium-heat 등급에 해당되었으며, 조제분유의 유청단백질 열변성율을 측정한 결과, 분말상에서는 $1.1{\sim}69.4%$였고 액상에서는 $37.4{\sim}71.3%$이었다.

• Clinical and Experimental Pediatrics
• /
• 제50권8호
• /
• pp.752-756
• /
• 2007

목 적 : 만성 기능성 변비 환아의 치료에서 PEG 4000과 락툴로스의 임상적 효용성에 대해 비교 분석 하였다. 방 법 : 2004년 9월부터 2007년 2월까지 노원 을지병원 소아과에 만성 반복성 복통이나 배변 장애를 주소로 내원하여 만성 기능성 변비로 치료받고 1년간 외래 추적이 가능했던 환아 56명을 대상으로 하였다. 전해질이 함유되지 않은 PEG 4000을 투여한 24명의 환아와 락툴로스를 투여한 32명의 환아들을 대상으로 치료 시작시와 치료 1개월, 3개월, 6개월, 1년 후에 각 약물의 효과와 부작용에 대해 비교 분석하였다. 결 과 : 두 군 모두 배변 횟수가 치료전에 비해 유의하게 증가하였고(P<0.05), 복통 또한 치료 전에 비해 유의한 감소가 있었다(P<0.05). 치료를 시작한 시점에서 12개월이 되었을 때 변비와 유분증으로부터의 회복은 PEG 투여군에서는 12례(60%)에서, 락툴로스 투여군에서는 15례(57.7%)에서 있었으며 두 군 간에 유의한 차이는 없었다. 결 론 : 유소아 만성 변비에서 PEG 4000과 락툴로스는 장기적 유지 요법으로 안전하고 효과적인 약물이며 변비와 유분증으로부터의 회복에 두 군간에 유의한 차이는 없었다.

• 농업과학연구
• /
• 제48권4호
• /
• pp.965-973
• /
• 2021

The intention of this research is to analyze the effects of lactulose (LAC) supplementation on the growth performance, nutrient digestibility, microbial shedding, and fecal noxious gas emissions on weaning pigs in a 42-day trial. Based on the initial body weight and sex, a total of 255 piglets (21 day old) were randomly allocated into one of three dietary treatments with 15 replications and five pigs (two female and three male) per pen. The dietary treatments were as follows: a corn-soybean meal-based basal diet (CON) supplemented with 0, 1, and 2 g·kg^-1 of LAC. During phase 1, significant (p < 0.05) increases in the average daily feed intake and average daily gain (ADG) were observed, whereas during phase 2 and overall experimental period, significant improvements (p < 0.05) in the body weight, ADG, and gain to feed ratio were observed in pigs fed a graded level of LAC compared to those fed the CON diet. Additionally, dietary LAC supplementation significantly improved (p < 0.05) the nutrient digestibility dry matter, nitrogen, and gross energy in both phase 1 and phase 2. Moreover, the inclusion of LAC supplementation significantly increased (p < 0.05) the fecal Lactobacillus counts and reduced (p > 0.05) the E. coli counts in pigs. Furthermore, LAC supplementation reduced (p > 0.05) fecal ammonia and hydrogen sulfide gas emissions during phase 2. The results here indicate that the addition of lactulose at 1 g·kg^-1 and/or 2 g·kg^-1 would be optimal to improve the performance outcomes of weaning piglets.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제19권3호
• /
• pp.186-192
• /
• 2016

Purpose: To evaluate the correlation between colon transit time (CTT) test value and initial maintenance dose of polyethylene glycol (PEG) 4000 or lactulose. Methods: Of 415 children with chronic functional constipation, 190 were enrolled based on exclusion criteria using the CTT test, defecation diary, and clinical chart. The CTT test was performed with prior disimpaction. The laxative dose for maintenance was determined on the basis of the defecation diary and clinical chart. The Shapiro-Wilk test and Pearson's and Spearman's correlations were used for statistical analysis. Results: The overall group median value and interquartile range of the CTT test was 43.8 (31.8) hours. The average PEG 4000 dose for maintenance in the overall group was $0.68{\pm}0.18g/kg/d$; according to age, the dose was $0.73{\pm}0.16g/kg/d$ (<8 years), $0.53{\pm}0.12g/kg/d$ (8 to <12 years), and $0.36{\pm}0.05g/kg/d$ (12 to 15 years). The dose of lactulose was $1.99{\pm}0.43mL/kg/d$ (<8 years) or $1.26{\pm}0.25mL/kg/d$ (8 to <12 years). There was no significant correlation between CTT test value and initial dose of laxative, irrespective of the subgroup (encopresis, abnormal CTT test subtype) for either laxative. Even in the largest group (overall, n=109, younger than 8 years and on PEG 4000), the correlation was weak (Pearson's correlation coefficient [R]=0.268, p=0.005). Within the abnormal transit group, subgroup (n=73, younger than 8 years and on PEG 4000) correlation was weak (R=0.267, p=0.022). Conclusion: CTT test value cannot predict the initial maintenance dose of PEG 4000 or lactulose with linear correlation.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제18권4호
• /
• pp.230-237
• /
• 2015

Purpose: Various gastrointestinal factors may contribute to maladaptive behavior in children with autism spectrum disorders (ASD). To determine the association between maladaptive behavior in children with ASD and gastrointestinal symptoms such as severity, intestinal microbiota, inflammation, enterocyte damage, permeability and absorption of opioid peptides. Methods: This observational cross-sectional study compared children with ASD to healthy controls, aged 2-10 years. Maladaptive behavior was classified using the Approach Withdrawal Problems Composite subtest of the Pervasive Developmental Disorder Behavior Inventory. Dependent variables were gastrointestinal symptom severity index, fecal calprotectin, urinary D-lactate, urinary lactulose/mannitol excretion, urinary intestinal fatty acids binding protein (I-FABP) and urinary opioid peptide excretion. Results: We did not find a significant difference between children with ASD with severe or mild maladaptive behavior and control subjects for gastrointestinal symptoms, fecal calprotectin, urinary D-lactate, and lactulose/mannitol ratio. Urinary opioid peptide excretion was absent in all children. Children with ASD with severe maladaptive behavior showed significantly higher urinary I-FABP levels compared to those with mild maladaptive behavior (p=0.019) and controls (p=0.015). Conclusion: In our series, maladaptive behavior in ASD children was not associated with gastrointestinal symptoms, intestinal inflammation (no difference in calprotectin), microbiota (no difference in urinary D-lactate) and intestinal permeability (no difference in lactulose/manitol ratio). ASD children with severe maladaptive behavior have significantly more enterocyte damage (increased urinary I-FABP) than ASD children with mild maladaptive behavior and normal children.

• 대한화장품학회지
• /
• 제42권4호
• /
• pp.367-375
• /
• 2016

본 연구에서는 락툴로스(lactulose) 51.67%와 갈락토올리고당(galactooligo saccharides) 15.8%로 이루어진 듀올리고(DuOligo)의 섭취를 통하여 피부개선 효능을 조사하였다. 40~60 대의 건강한 여성 37명을 대상으로 대조군(덱스트린)과 실험군(듀올리고군)으로 나누어 각각 8주 동안 섭취 후, 수분보유량, 경표피수 분손실량, 멜라닌지수, 홍반지수와 주름지수를 측정하였다. 그 결과, 듀올리고 섭취 8주 후의 수분 보유량은 대조군에 비하여 수분 보유량이 38.22% 유의적으로 증가하였다(p < 0.01). 대조군의 경피수분손실량은 8주후 $3.39g/h/m^2$로 감소한데 비하여 듀올리고군의 경피수분손실량은 8주후 $5.32g/h/m^2$ 감소하였다. 대조군의 멜라닌 지수는 시간에 따라 그 값이 유의적으로 증가하였으나, 듀올리고군의 멜라닌 지수는 시간에 따른 유의적 차이가 나타나지 않았다. 또한, 듀올리고군은 대조군에 비하여 주름의 총 넓이, 총 주름의 길이, 주름의 수 및 주름의 깊이가 확연하게 감소하였다(p < 0.05). 듀올리고의 피부개선 기능성 소재로서의 응용 가능성을 확인하였다.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제19권3호
• /
• pp.153-161
• /
• 2016

This paper covers algorithms for the management of regurgitation, constipation and infantile colic in infants. Anti-regurgitation formula may be considered in infants with troublesome regurgitation, while diagnostic investigations or drug therapy are not indicated in the absence of warning signs. Although probiotics have shown some positive evidence for the management of functional gastrointestinal disorders (FGIDs), the evidence is not strong enough to make a recommendation. A partially hydrolyzed infant formula with prebiotics and ${\beta}$-palmitate may be considered as a dietary intervention for functional constipation in formula fed infants. Lactulose has been shown to be effective and safe in infants younger than 6 months that are constipated. Macrogol (polyethylene glycol, PEG) is not approved for use in infants less than 6 months of age. However, PEG is preferred over lactulose in infants >6 months of age. Limited data suggests that infant formula with a partial hydrolysate, galacto-oligosaccharides/fructo-oligosaccharides, added ${\beta}$-palmitate may be of benefit in reducing infantile colic in formula fed infants in cases where cow's milk protein allergy (CMPA) is not suspected. Evidence suggests that the use of extensively hydrolyzed infant formula for a formula-fed baby and a cow's milk free diet for a breastfeeding mother may be beneficial to decrease infantile colic if CMPA is suspected. None of the FGIDs is a reason to stop breastfeeding.

• Nutrition Research and Practice
• /
• 제10권6호
• /
• pp.583-589
• /
• 2016

BACKDROUND/OBJECTIVE: Constipation is a condition that can result from intestinal deformation. Because humans have an upright posture, the effects of gravity can cause this shape deformation. Oligosaccharides are common prebiotics and their effects on bowel health are well known. However, studies of the physiological functionality of a product that contains both lactulose and galactooligosaccharides are insufficient. We investigated the constipation reduction effect of a dual-type oligosaccharide, Dual-Oligo, in loperamide-treated rats. MATERIALS/METHODS: Dual-Oligo consists of galactooligosaccharides (15.80%) and lactulose (51.67%). Animals were randomly divided into four groups, the normal group (normal), control group (control), low concentration of Dual-Oligo (LDO) group, and high concentration of Dual-Oligo (HDO) group. After 7 days of oral administration, fecal pellet amount, fecal weight, watercontent of fecal were measured. Blood chemistry, short-chain fatty acid (SCFA), gastrointestinal transit ratio and length and intestinal mucosa were analyzed. RESULTS: Dual-Oligo increased the fecal weight, and water content of feces in rats with loperamide-induced constipation. Gastrointestinal transit ratio and length and area of intestinal mucosa significantly increased after treatment with Dual-Oligoin loperamide-induced rats. A high concentration of Dual-Oligo tended to produce more acetic acid than that observed for the control group, and Dual-Oligo affected the production of total SCFA. Bifidobacteria concentration of cecal contents in the high-concentration oligosaccharide (HDO) and low-concentration oligosaccharide (LDO) groups was similar to the result of the normal group. CONCLUSIONS: These results showed that Dual-Oligo is a functional material that is derived from a natural food product and is effective in ameliorating constipation.

• Journal of Dairy Science and Biotechnology
• /
• 제33권2호
• /
• pp.103-110
• /
• 2015

산양유을 섭취한 성인의 분변 내 bifidobacteria의 증식 효과 및 분변에서 분리된 bifidobacteria와 lactobacilli의 당 발효 능력을 조사하였다. 1. 산양유를 섭취한 처리군이 대조군보다 bifidobacteria 세균수가 상대적으로 높았으며, 8주에서 95% 신뢰한계에서 유의성이 있었다. 2. 분변에서 분리한 균주들을 13 균주의 16S rRNA 염기서 열로 동정한 결과, 산양유를 섭취한 처리구는 B. adolescentis, B. longum, B. pseudocatenulatum, B. dentium, L. sakei 순으로 분리되었다. 대조군의 12 균주는 B. adolescentis, B. longum, L. ruminis, L. sakei, B. pseudocatenulatum 순으로 분리되었다. 3. 산양유 올리고당과 lactulose는 모든 bifidobacteria 및 lactobacilli 균주가 발효하였다. Fructooligosaccaride는 B. adolescentis 7 균주 모두 발효하였다. 조사한 B. pseudocatenulatum 4 균주, L. sakei 3 균주, B. longum 7 균주 중에서 각각 3, 2, 1 균주가 fructooligosaccharide를 발효하였다.

• 약학회지
• /
• 제36권3호
• /
• pp.241-249
• /
• 1992

The whole body extract of Lunella coronata coreensis agglutinated nonspecifically human and other animal erythrocytes. A new lectin was purified by the following procedures: 0.15 M NaCl extraction, salt fractionation, gel filtration, anionic and cationic ion exchange column chromatographies. Through these purification procedures, specific activity of LCC-I was increased from 276 to 9714.3 units/mg, And on polyacrylamide gel electrophoresis, LCC-I exhibited one major band. A molecular weight of LCC-I was assumed to be 20,000 by sodium dodesyl sulfate polyacrylamide gel electrophoresis. The purified lectin was relatively stable at various pH and heat. Among the tested sugars, lactose and lactulose inhibited lectin activity at a concentration of 6.25 mM, respectively.